Cargando…

Biomarkers Associated with Cardiovascular Disease in COVID-19

Coronavirus disease-19 (COVID-19) emerged late December 2019 in the city of Wuhan, China and has since spread rapidly all over the world causing a global pandemic. While the respiratory system is the primary target of disease manifestation, COVID-19 has been shown to also affect several other organs...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kaufmann, Christoph C., Ahmed, Amro, Burger, Achim Leo, Muthspiel, Marie, Jäger, Bernhard, Wojta, Johann, Huber, Kurt
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8946710/ https://www.ncbi.nlm.nih.gov/pubmed/35326373 http://dx.doi.org/10.3390/cells11060922

Ejemplares similares

Direct cardiovascular complications and indirect collateral damage during the COVID-19 pandemic: A review
por: Burger, Achim Leo, et al.
Publicado: (2021)

Association of Interleukin-32 and Interleukin-34 with Cardiovascular Disease and Short-Term Mortality in COVID-19
por: Kaufmann, Christoph C., et al.
Publicado: (2023)

New Treatment Targets and Innovative Lipid-Lowering Therapies in Very-High-Risk Patients with Cardiovascular Disease
por: Burger, Achim Leo, et al.
Publicado: (2022)

Short dual antiplatelet therapy and dual antiplatelet therapy de-escalation after primary percutaneous intervention: For whom and how
por: Muthspiel, Marie, et al.
Publicado: (2022)

Improvement of outcome prediction of hospitalized patients with COVID-19 by a dual marker strategy using high-sensitive cardiac troponin I and copeptin
por: Kaufmann, Christoph C., et al.
Publicado: (2021)

The LIPL study: Postprandial lipid profile, inflammation, and platelet activity in patients with chronic coronary syndrome
por: Pogran, Edita, et al.
Publicado: (2023)

Red Cell Distribution Width Upon Hospital Admission Predicts Short-Term Mortality in Hospitalized Patients With COVID-19: A Single-Center Experience
por: Kaufmann, Christoph C., et al.
Publicado: (2021)

Increased platelet reactivity in dyslipidemic patients with coronary artery disease on dual anti-platelet therapy
por: Jäger, Bernhard, et al.
Publicado: (2018)

Prothrombotic Milieu, Thrombotic Events and Prophylactic Anticoagulation in Hospitalized COVID-19 Positive Patients: A Review
por: Cryer, Michael Joseph, et al.
Publicado: (2022)

The Paradigm Change of IL-33 in Vascular Biology
por: Demyanets, Svitlana, et al.
Publicado: (2021)

G-CSF Predicts Cardiovascular Events in Patients with Stable Coronary Artery Disease
por: Katsaros, Katharina M., et al.
Publicado: (2015)

Changes in Circulating Extracellular Vesicles in Patients with ST-Elevation Myocardial Infarction and Potential Effects of Remote Ischemic Conditioning—A Randomized Controlled Trial
por: Haller, Paul M., et al.
Publicado: (2020)

Human cardiac fibroblasts express B-type natriuretic peptide: fluvastatin ameliorates its up-regulation by interleukin-1α, tumour necrosis factor-α and transforming growth factor-β
por: Jarai, Rudolf, et al.
Publicado: (2009)

The adipokine vaspin is associated with decreased coronary in-stent restenosis in vivo and inhibits migration of human coronary smooth muscle cells in vitro
por: Kastl, Stefan P., et al.
Publicado: (2020)

Soluble ST2 in Patients with Carotid Artery Stenosis—Association with Plaque Morphology and Long-Term Outcome
por: Stojkovic, Stefan, et al.
Publicado: (2023)

Circulatory miR-411-5p as a Novel Prognostic Biomarker for Major Adverse Cardiovascular Events in Patients with Atrial Fibrillation
por: Nopp, Stephan, et al.
Publicado: (2023)

Cardiovascular biomarkers in COVID-19
por: Omland, Torbjørn, et al.
Publicado: (2021)

Commentary on “Elevated plasma levels of plasminogen activator inhibitor‐1 are associated with risk of future incident venous thromboembolism”: A new role for plasminogen activator inhibitor‐1—An inhibitor of fibrinolysis predicts future venous thromboembolic events and links them to obesity
por: Wojta, Johann
Publicado: (2022)

High altitude thrombosis—Evidence for underlying mechanisms from a large prospective longitudinal study
por: Wojta, Johann
Publicado: (2022)

Urokinase plasminogen activator protects cardiac myocytes from oxidative damage and apoptosis via hOGG1 induction
por: Hohensinner, Philipp J., et al.
Publicado: (2017)

Is diversity harmful?—Mixed-brand cardiac implantable electronic devices undergoing magnetic resonance imaging
por: König, Christoph Alexander, et al.
Publicado: (2021)

Soluble ST2 as a Potential Biomarker for Abdominal Aortic Aneurysms—A Single-Center Retrospective Cohort Study
por: Klopf, Johannes, et al.
Publicado: (2022)

Copeptin Predicts Mortality in Critically Ill Patients
por: Krychtiuk, Konstantin A., et al.
Publicado: (2017)

Soluble ST2 and Interleukin-33 Levels in Coronary Artery Disease: Relation to Disease Activity and Adverse Outcome
por: Demyanets, Svitlana, et al.
Publicado: (2014)

Monocyte subsets predict mortality after cardiac arrest
por: Krychtiuk, Konstantin A., et al.
Publicado: (2020)

Cardioprotective cytokine interleukin‐33 is up‐regulated by statins in human cardiac tissue
por: Pentz, Richard, et al.
Publicado: (2018)

Non-bacterial thrombotic endocarditis in the context of pulmonary adenocarcinoma: a case report
por: Kaufmann, Christoph C, et al.
Publicado: (2020)

Components of the interleukin-33/ST2 system are differentially expressed and regulated in human cardiac cells and in cells of the cardiac vasculature
por: Demyanets, Svitlana, et al.
Publicado: (2013)

Effects of Nicorandil on Inflammation, Apoptosis and Atherosclerotic Plaque Progression
por: Lenz, Max, et al.
Publicado: (2021)

Plasma Levels of snoRNAs are Associated with Platelet Activation in Patients with Peripheral Artery Disease
por: Nossent, Anne Yaël, et al.
Publicado: (2019)

The anti-angiogenic factor PEDF is present in the human heart and is regulated by anoxia in cardiac myocytes and fibroblasts
por: Rychli, Kathrin, et al.
Publicado: (2010)

An increase of interleukin-33 serum levels after coronary stent implantation is associated with coronary in-stent restenosis
por: Demyanets, Svitlana, et al.
Publicado: (2014)

Platelet Turnover Predicts Outcome after Coronary Intervention
por: Freynhofer, Matthias K., et al.
Publicado: (2017)

Exploring the link between risk perception in internet media and the prevalence of COVID-19 in Europe
por: Jarynowski, Andrzej, et al.
Publicado: (2021)

The cardiovascular disorders and prognostic cardiac biomarkers in COVID-19
por: Shi, Xingjuan, et al.
Publicado: (2021)

Neutrophil Extracellular Trap Degradation by Differently Polarized Macrophage Subsets
por: Haider, Patrick, et al.
Publicado: (2020)

Biomarkers of Cardiovascular Disease
por: Huang, Ying, et al.
Publicado: (2017)

Soluble neprilysin and survival in critically ill patients
por: Lenz, Max, et al.
Publicado: (2022)

Technology and cardiovascular diseases in the era of COVID‐19
por: Harky, Amer, et al.
Publicado: (2020)

A short introduction to the HUG Cardiovascular Center and The next quantum leap in Cardiovascular Medicine
por: Huber, Christoph
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ioout5evudoj3errnj6aentvsf